Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Sci Rep ; 13(1): 9820, 2023 06 17.
Artículo en Inglés | MEDLINE | ID: mdl-37330527

RESUMEN

Bacteria in the genus Streptomyces are found ubiquitously in nature and are known for the number and diversity of specialized metabolites they produce, as well as their complex developmental lifecycle. Studies of the viruses that prey on Streptomyces, known as phages, have aided the development of tools for genetic manipulation of these bacteria, as well as contributing to a deeper understanding of Streptomyces and their behaviours in the environment. Here, we present the genomic and biological characterization of twelve Streptomyces phages. Genome analyses reveal that these phages are closely related genetically, while experimental approaches show that they have broad overlapping host ranges, infect early in the Streptomyces lifecycle, and induce secondary metabolite production and sporulation in some Streptomyces species. This work expands the group of characterized Streptomyces phages and improves our understanding of Streptomyces phage-host dynamics.


Asunto(s)
Bacteriófagos , Streptomyces , Bacteriófagos/genética , Streptomyces/genética , Metabolismo Secundario/genética , Genoma Viral , Genómica , Filogenia
2.
Nat Commun ; 11(1): 4608, 2020 09 14.
Artículo en Inglés | MEDLINE | ID: mdl-32929085

RESUMEN

Actinobacteria produce antibacterial and antifungal specialized metabolites. Many insects harbour actinobacteria on their bodies or in their nests and use these metabolites for protection. However, some actinobacteria produce metabolites that are toxic to insects and the evolutionary relevance of this toxicity is unknown. Here we explore chemical interactions between streptomycetes and the fruit fly Drosophila melanogaster. We find that many streptomycetes produce specialized metabolites that have potent larvicidal effects against the fly; larvae that ingest spores of these species die. The mechanism of toxicity is specific to the bacterium's chemical arsenal: cosmomycin D producing bacteria induce a cell death-like response in the larval digestive tract; avermectin producing bacteria induce paralysis. Furthermore, low concentrations of volatile terpenes like 2-methylisoborneol that are produced by streptomycetes attract fruit flies such that they preferentially deposit their eggs on contaminated food sources. The resulting larvae are killed during growth and development. The phenomenon of volatile-mediated attraction and specialized metabolite toxicity suggests that some streptomycetes pose an evolutionary risk to insects in nature.


Asunto(s)
Bacterias/metabolismo , Drosophila melanogaster/citología , Drosophila melanogaster/microbiología , Actinobacteria/fisiología , Animales , Antraciclinas/farmacología , Antibacterianos/química , Antibacterianos/farmacología , Canfanos/toxicidad , Muerte Celular/efectos de los fármacos , Drosophila melanogaster/efectos de los fármacos , Larva/efectos de los fármacos , Larva/microbiología , Metaboloma , Esporas Bacterianas/metabolismo , Esporas Bacterianas/fisiología , Streptomyces/fisiología , Análisis de Supervivencia , Compuestos Orgánicos Volátiles/farmacología
3.
Elife ; 62017 01 03.
Artículo en Inglés | MEDLINE | ID: mdl-28044982

RESUMEN

It has long been thought that the life cycle of Streptomyces bacteria encompasses three developmental stages: vegetative hyphae, aerial hyphae and spores. Here, we show interactions between Streptomyces and fungi trigger a previously unobserved mode of Streptomyces development. We term these Streptomyces cells 'explorers', for their ability to adopt a non-branching vegetative hyphal conformation and rapidly transverse solid surfaces. Fungi trigger Streptomyces exploratory growth in part by altering the composition of the growth medium, and Streptomyces explorer cells can communicate this exploratory behaviour to other physically separated streptomycetes using an airborne volatile organic compound (VOC). These results reveal that interkingdom interactions can trigger novel developmental behaviours in bacteria, here, causing Streptomyces to deviate from its classically-defined life cycle. Furthermore, this work provides evidence that VOCs can act as long-range communication signals capable of propagating microbial morphological switches.


Asunto(s)
Hongos/metabolismo , Interacciones Microbianas , Transducción de Señal , Streptomyces/efectos de los fármacos , Streptomyces/fisiología , Compuestos Orgánicos Volátiles/metabolismo , Medios de Cultivo/química
4.
J Ind Microbiol Biotechnol ; 43(2-3): 233-48, 2016 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-26433385

RESUMEN

Environmental microbes produce biologically active small molecules that have been mined extensively as antibiotics and a smaller number of drugs that act on eukaryotic cells. It is known that there are additional bioactives to be discovered from this source. While the discovery of new antibiotics is challenged by the frequent discovery of known compounds, we contend that the eukaryote-active compounds may be less saturated. Indeed, despite there being far fewer eukaryotic-active natural products these molecules interact with a far richer diversity of molecular and cellular targets.


Asunto(s)
Bacterias/química , Productos Biológicos/farmacología , Eucariontes/efectos de los fármacos , Eucariontes/metabolismo , Animales , Antibacterianos/aislamiento & purificación , Antibacterianos/farmacología , Productos Biológicos/química , Productos Biológicos/aislamiento & purificación , Eucariontes/química , Eucariontes/citología , Humanos , Terapia Molecular Dirigida
5.
ACS Chem Biol ; 10(11): 2616-23, 2015 Nov 20.
Artículo en Inglés | MEDLINE | ID: mdl-26352211

RESUMEN

Most existing antibiotics were discovered through screens of environmental microbes, particularly the streptomycetes, for the capacity to prevent the growth of pathogenic bacteria. This "activity-guided screening" method has been largely abandoned because it repeatedly rediscovers those compounds that are highly expressed during laboratory culture. Most of these metabolites have already been biochemically characterized. However, the sequencing of streptomycete genomes has revealed a large number of "cryptic" secondary metabolic genes that are either poorly expressed in the laboratory or that have biological activities that cannot be discovered through standard activity-guided screens. Methods that reveal these uncharacterized compounds, particularly methods that are not biased in favor of the highly expressed metabolites, would provide direct access to a large number of potentially useful biologically active small molecules. To address this need, we have devised a discovery method in which a chemical elicitor called Cl-ARC is used to elevate the expression of cryptic biosynthetic genes. We show that the resulting change in product yield permits the direct discovery of secondary metabolites without requiring knowledge of their biological activity. We used this approach to identify three rare secondary metabolites and find that two of them target eukaryotic cells and not bacterial cells. In parallel, we report the first paired use of cheminformatic inference and chemical genetic epistasis in yeast to identify the target. In this way, we demonstrate that oxohygrolidin, one of the eukaryote-active compounds we identified through activity-independent screening, targets the V1 ATPase in yeast and human cells and secondarily HSP90.


Asunto(s)
Acetanilidas/química , Actinobacteria/química , Actinobacteria/metabolismo , Antibacterianos/biosíntesis , Antibacterianos/aislamiento & purificación , Productos Biológicos/química , Descubrimiento de Drogas/métodos , Macrólidos/química , Éteres Fenílicos/química , Acetanilidas/farmacología , Actinobacteria/genética , Actinobacteria/crecimiento & desarrollo , Antibacterianos/química , Antibacterianos/farmacología , Bacterias/efectos de los fármacos , Productos Biológicos/metabolismo , Cromatografía Liquida , Proteínas HSP90 de Choque Térmico/antagonistas & inhibidores , Macrólidos/farmacología , Éteres Fenílicos/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...